Effect of FTY720 and ICAM-1 mAb mono and combination therapy in cardiac allo-transplantation in rats

  • Xiong Hai-bo Email author
  • Huang Zu-fa 
  • Xia Sui-sheng 
  • Ye Qi-fa 
  • Wen Hao 


Objective To observe the effect of FTY720 and ICAM-1 mAb mono and combination therapy in cardiac allo-transplantation in rats. Methods Rats were randomly assigned to 9 groups, heart allo-transplantation were performed in abdominal site with micro-surgical technique. Recipients with allografts were treated with different doses of FTY720 and (or) ICAM-1 mAb. Graft survival, histopathology and level of serum IL-2, IFN-γ, IL-4, IL-10 were investigated. Results Low doses of FTY720 (1mg/kg) combined with ICAM-1 mAb achieved synergistic effect in the prolongation of cardiac graft survival, combination index(CI)=0.67. Conclusion Concomitant therapy of FTY720 and ICAM-1 mAb achieved a synergistic effect in the prolongation of heart allograft survival in rats.

Key words

FTY720 ICAM-1 mAb synergy rat heart transplantation immune tolerance rejection 

CLC number



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    XIONG Hai-bo, WEN Hao. Comparison of rat allocardiac transplantation model in cervical and abdominal site [J]. Journal of XingJiang Medical University, 2003, 26(4): 355–357.MathSciNetGoogle Scholar
  2. [2]
    Billingham M E, Cary N R, Hammond M E, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group [J]. J Heart Transplant, 1990, 9(6): 587–593.Google Scholar
  3. [3]
    Chou T C. The median-effect principle and combination index for quantitation of synergism and antagonism[A]. Chou T C, Rideout D. Synergism and Antagonism in Chemotherapy[C]. San Diego: Academic Press, 1991.Google Scholar
  4. [4]
    Kimura T, Hasegawa T, Nakai H, et al. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells [J]. Transplantation, 2003, 75(9): 1469–1474.CrossRefGoogle Scholar
  5. [5]
    Chiba K, Hoshino Y, Ohtsuki M, et al. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. prevention of allograft rejection inrats and dogs by FTY720 and FTY720-phosphate [J]. Transplant Proc, 2005, 37(1): 102–106.CrossRefGoogle Scholar
  6. [6]
    Pinschewer D D, Ochsenbein A F, Odermatt B, et al. FTY720 immunosuppression impairs effector T-cell peripheral homing without affecting induction, expansion, and memory [J]. J Immunol, 2000, 164 (1): 5761–5770.CrossRefGoogle Scholar
  7. [7]
    Hoshino Y, Yanagawa Y, Ohtsuki M, et al. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK506 in rat allograft models[J]. Transplant Proc, 1999, 31(1–2): 1224–1226.CrossRefGoogle Scholar
  8. [8]
    Grochowiecki T, Gotoh M, Dono K, et al. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ICAM-1 pathway [J]. Transplantation, 2000, 69(8): 1567–1571.CrossRefGoogle Scholar
  9. [9]
    Isobe M, Yagita H, Okumura K, et al. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1[J]. Science, 1992, 255(5048): 1125–1127.CrossRefGoogle Scholar
  10. [10]
    Pietersz G A, Sandrin M S, Ling S, et al. LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival[J]. Transpl Immunol, 2001, 9(1): 7–11.CrossRefGoogle Scholar
  11. [11]
    Saggi B H, Fisher R A, Bu D, et al. Intra-graft cytokine expression and tolerance induction in rat renal allografts[J]. Transplantation, 1999, 67(2): 206–210.CrossRefGoogle Scholar

Copyright information

© Central South University 2005

Authors and Affiliations

  • Xiong Hai-bo 
    • 1
    Email author
  • Huang Zu-fa 
    • 1
  • Xia Sui-sheng 
    • 2
  • Ye Qi-fa 
    • 1
  • Wen Hao 
    • 3
  1. 1.Institute of Transplantation, the Third Xiangya HospitalCentral South UniversityChangshaChina
  2. 2.Department of General Surgery, the First Affiliated HospitalXinjiang Medical UniversityUrumqiChina
  3. 3.Institute of TransplantationTongji Hospital of Huazhong Science and Technological UniversityWuhanChina

Personalised recommendations